Skip to main content
. 2020 Jul 14;50(10):1785–1812. doi: 10.1007/s40279-020-01317-5

Table 3.

Results from sensitivity analyses with data from studies including performance as the primary outcome

Sensitivity analysis Analysis details Effect size Between study variance Intraclass correlation Probability of small effect
Between group: oral contraceptive pill withdrawal versus the early follicular phase of the menstrual cycle 34 effect sizes from 11 studies (combined quality = H/M/L; 27% H; 27% M; 27% L; 18% VL) 0.14 [− 0.14–0.38] 0.20 [0.01–0.59] 0.28 [0.0–0.82] (d ≥ 0.2; p = 0.323; d ≤  − 0.2; p = 0.014)
Between group: oral contraceptive pill consumption versus all phases of the menstrual cycle except the early follicular phase 57 effect sizes from 16 studies (combined quality = M; 26.7% H; 33.3% M; 26.7% L; 13.3% VL) 0.14 [− 0.03–0.31] 0.10 [0.0–0.40] 0.42 [0.0–0.86] (d ≥ 0.2; p = 0.257; d ≤  − 0.2; p = 0.001)
Within group: oral contraceptive pill consumption with oral contraceptive pill withdrawal 141 effect sizes from 21 studies (combined quality = H/M; 33.3% H; 33.3% M; 19.1% L; 14.3% VL) 0.05 [− 0.03–0.11] 0.06 [0.0–0.17] 0.19 [0.0–0.66] (|d|≥ 0.2; p < 0.001)

Results are from multilevel random effects models with median parameter estimates and 95% credible intervals (95% CrI)

H high, M moderate, L low, VL very low